• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2020 Fiscal Year Final Research Report

Generation and characterization of BCOR-ITD tumor models

Research Project

  • PDF
Project/Area Number 18K07057
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 49030:Experimental pathology-related
Research InstitutionNational Center for Child Health and Development

Principal Investigator

Ueno Hitomi  国立研究開発法人国立成育医療研究センター, 小児血液・腫瘍研究部, 研究員 (30435630)

Co-Investigator(Kenkyū-buntansha) 高田 修治  国立研究開発法人国立成育医療研究センター, システム発生・再生医学研究部, 部長 (20382856)
Project Period (FY) 2018-04-01 – 2021-03-31
Keywords小児腫瘍 / BCOR / ゲノム編集
Outline of Final Research Achievements

To elucidate how BCOR internal tandem duplication (BCOR-ITD) causes tumorigenesis, we attempted to generate model mice and model cells with Bcor-ITD. In this study, we applied genome editing in fertilized eggs, which resulted in unintended mutations in some cells, making it difficult to create a line of Bcor-ITD mice. However, we succeeded in establishing Bcor-ITD positive ES cells and fibroblasts from heterozygote mice.
The Bcor-ITD-expressing fibroblast cell line showed an upward trend in the expression of Bcor compared to the wild-type expressing line. In fibroblasts, when the activated X chromosome was Bcor-ITD, the gene expression of Bcor tended to increase than that of the wild type. This result is consistent with the over expression of BCOR-ITD in clear cell sarcoma of the kidney, suggests that mutation acquisition may result in regulated BCOR gene expression.

Free Research Field

小児腫瘍

Academic Significance and Societal Importance of the Research Achievements

変異モデルは、様々な遺伝子変異の機能解析や治療薬開発に必須である。
本研究では小児固形腫瘍で発見したBCOR変異(BCOR-ITD)を有するマウスモデル細胞を作出し、その分子生物学的解析から腫瘍で認める特徴の一部が、変異獲得により生じていると推測できる結果を得た。また変異を有するES細胞を樹立したことにより、今後、BCOR-ITDによる異常な細胞分化や腫瘍化の観察について可能性が広がった。本研究の成果は、BCOR-ITD陽性腫瘍の解明に向けた足掛かりになったと考える。

URL: 

Published: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi